 |
인쇄하기
취소
|
Kyungnam set to join prescription market
Kyungnam Pharm, a local OTC maker, has signed a memorandum of understanding with the Korean Association for Vitamin Research to develop DETOX (detoxication therapy), according to a company spokesperson.
The company plans to invest 20 billion won in the development of new drugs for five years.
Kyungnam chairman Lee Hee-chul said, “We will endeavor to create new medicines under closer colla...
The company plans to invest 20 billion won in the development of new drugs for five years.
Kyungnam chairman Lee Hee-chul said, “We will endeavor to create new medicines under closer colla...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.